Neurimmune Appoints Fabian Buller as CBONeurimmune today announced that it has appointed Dr. Fabian Buller to the newly created position Chief Business Officer. Dr. Buller joins Neurimmune’s executive team and brings 8 years of professional … more ➔
Concept appoints Matilda Bingham & David HigtonConcept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed Matilda Bingham as Site Director of its Alderley Park site … more ➔
Redx appoints Lisa Anson as new Chief Executive OfficerRedx Pharma announced today that it has appointed Lisa Anson as Chief Executive Officer (CEO) and to its Board of Directors. Lisa will take up both roles on 1 June 2018. At that time Iain Ross, currently … more ➔
Sanofi names John Reed as new Head of Global R&DElias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the … more ➔
Sanofi names John Reed as new Head of Global R&DElias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the … more ➔
Abivax appoints Alexandra Pearce as VP of Regulatory AffairsDr. Pearce Joins as ABIVAX Works with FDA and EMA on Next Stage Developments of its Clinical Product Candidates more ➔
Commense Appoints Edward J. Stewart as President and CEOCommense, Inc., an affiliate of PureTech Health plc developing microbiome-derived immune modulators for paediatric and maternal health, today announced the appointment of Edward J. Tad Stewart as President … more ➔
Nordic Nanovector’s Luigi Costa to step down as CEONordic Nanovector ASA announces that Luigi Costa will step down as Chief Executive Officer by mutual agreement with the Board of Directors. A search for a new CEO will begin immediately. To ensure a … more ➔
Namal Nawana appointed CEO of Smith & NephewSmith & Nephew plc today announced the appointment of Namal Nawana as Chief Executive Officer. He will join the Company and be appointed to the Board as an Executive Director on 7 May 2018. more ➔
Abeona Therapeutics Appoints Carsten Thiel as CEOAbeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of … more ➔
